Don’t get caught with dirty data

In any given landscape, there’s going to be some dirt.

You need tools to help you see where to dig deeper. Some types of information you want to scan at the family level and some you want to dig down to individual family members. You might want to see one priority date per family but legal status for each member. Sequences add another layer of complexity with multiple sequences per patent document.

The latest tools in the BizInt Smart Charts product family will help you create accurate and useful patent reports — with the right level of detail to help you decide where to start digging.

Get a Closer Look! Go to www.bizint.com/CookbookThe Cookbook of Reports and Visualizations shows how you can use BizInt Smart Charts software to create, customize and distribute

competitive intelligence reports and visualizations from drug pipeline, clinical trial, patent and gene sequence databases.

The BizInt Smart Charts product family is used by pharmaceutical, biotech and medical device/

diagnostics companies worldwide to support product lifecycle planning and management.

Visit us in the exhibit hall for samples and a demonstration!

BizInt Solutions, Inc.1.714.289.1000www.bizint.com

Software for Business Intelligence

PIUG 2014 Biotechnology Conference

PATENT INFORMATION USERS GROUP, INC.

February 24-26, 2014

Genzyme, Inc. Cambridge, Massachusetts

Meeting Book prepared by BizInt Solutions, Inc., a proud sponsor of the PIUG Biotechnology Meeting

Staying on the Cutting Edge of Biotechnology Patent Searching

The International Society for Patent Information

PIUG 2014 Biotechnology ConferenceTuesday, February 25, 2014 Genzyme, Inc., Cambridge MA

7:30 am 7:50 am Registration and Vendor Exhibits

7:50 am 8:15 am Welcome to the PIUG 2014 Biotechnology Conference.

8:15 am 8:45 am Hindsight analysis of litigation-based investigations on best-practice searching for non-litigation matters. David A. Casimir (Casimir Jones, S.C.)

8:45 am 9:15 am Therapeutic Antibodies: Do’s and Don’ts for Freedom-to-Operate and Patentability Searching. Briana Erickson (Nelson Mullins Riley & Scarborough LLP)

9:15 am 9:45 am Please replace with Striding Along the Cutting Edge of Biopatent Searching. Barbara Miller (Novartis Institutes for Biomedical Research)

9:45 am 10:00 am Product Reviews (BizInt, Linguamatics, STN)

10:00 am 10:30 am Break & Vendor Exhibits

10:30 am 11:00 am The Impact of WIPO Standards on Sequence Searching. Tara Rix & Tasha Witham (Harbor Consulting IP)

11:00 am 11:30 am Erroneous Patent Sequence ID Numbers in Major Sequence Databases. Ellen Sherin (Dupont)

11:30 am 11:45 am Product Reviews (EBSCO, GenomeQuest, INTELLIXIR)

11:45 am 1:15 pm Lunch and Exhibits

1:15 pm 1:45 pm Development of CAMBIA, the Lens, and PatSeq Explorer: public global patent search resources. Richard Jefferson (CAMBIA, Australia)

1:45 pm 2:15 pm Patent Databases Available from SIPO with a Focus on Searching China Medicine Patents. Binqiang Liu (Univ. of New Hampshire School of Law)

2:15 pm 2:30 pm Product Reviews (Minesoft, Search Technology, TPRI)

2:30 pm 3:00 pm Break & Vendor Exhibits

3:00 pm 3:30 pm A “Cheat Sheet” for Exclusivities - Learning Across Functional Groups. Bo Peng

3:30 pm 5:00 pm Discussion Panel: How I Became a Biotechnology Patent Searcher. Gin Eggerichs, Ken Hoppe, Seth Mendelson, Ellen Sherin, and Alison Taylor

5:00 pm 5:15 pm Closing Remarks.

5:15 pm 5:30 pm Genzyme Tour.

6:00 pm Networking Dinner.

Photo by Qin Meng. Genzyme photos courtesy of Genzyme.

1

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

Table of contents

Conference Committee 2

Floor Plan of the Venue 3

Thank you to Sponsors 4

Tuesday morning speakers 5

Tuesday afternoon speakers 14

Gold Sponsors 22

Silver Sponsors 25

Attendees by name 28

Attendees by company 29

Workshops 30

MESSAGE FROM THE CHAIR

Dear PIUG Biotechnology Conference attendees,

Welcome to the PIUG’s eighth annual Biotechnology Conference! This year’s program is simply outstanding with so many practical and professionally enriching presentations from a variety of knowledgeable professionals within the field of biotechnology. It is definitely an event that will help you to stay on the cutting edge of biotechnology patent searching. I offer my sincere and heartfelt thanks for the countless number of hours the Biotechnology Conference volunteers have generously devoted to making this professional event stand out! I congratulate and thank Qin Meng and Monica Weiss-Nolen, who are the Co-Chairs of the Planning Committee for organizing and coordinating this year’s conference to be at the Genzyme Center. I would also like to thank Genzyme for its generosity and hospitality in agreeing to host this important professional and educational event.

In organizing this conference, Qin and Monica were assisted by many equally dedicated volunteers each of whom I would like to congratulate and thank as follows – Helen Oen, Alison Taylor, Barbara Miller, Bo Peng, Greg Roland and Kim Spytek, all of whom in addition to Qin are members of the Program Committee and Ken Koubek, Donna Fisher, Elyse Turner, Ruben Diaz, Kristine Atkinson, Christine Geluk, Sherri Voebel, Rick Williams, Tom Wolff, Diane Webb and Jim Brown all of whom are members of the Planning Committee. It is very evident that each of you have put in considerable effort to make the conference a high quality and professional event. All of you deserve a rousing round of applause. Please help me thank them by approaching and congratulating each of these volunteers on a job well done!

I would also like to thank our very generous sponsors. Without your continued support, the PIUG would not be able to provide such valuable educational opportunities for the patent information community. This year’s sponsors for the PIUG Biotechnology Conference are BizInt, Linguamatics, STN, EBSCO, GenomeQuest, Intellixir, Minesoft, TPR, Search Technology/VantagePoint and Dialog/Proquest. I encourage all of you to visit the exhibition booths during the breaks to learn about the new and exciting developments these companies are delivering to make biotechnology related information more accessible.

Finally, I would like to personally thank all of you – our members who attend the PIUG conferences, who volunteer their time and who loyally support the organization year after year. You are the heart of this organization and your support of the PIUG is absolutely critical to its success.

Best regards, Susanne Hantos – PIUG Chair

2

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

2014 PROGRAM COMMITTEEHelen Oen, Co-ChairAlison Taylor, Co-ChairQin MengBarbara MillerBo PengGreg RolandKim Spytek

2014 PLANNING COMMITTEEPlanning Co-chairs Qin Meng and Monica Weiss-NolenBoard Liaison Jim BrownEvaluation Christine GelukExhibitor Liaison Qin MengMeeting Book Diane Webb Alison TaylorHospitality / Travel Rick WilliamsOn-Site Logistics Greg RolandOn-Site Photographers Qin Meng Greg RolandPublicity Kristine AtkinsonRegistration Ken Koubek Donna FisherSignage Qin MengWeb Pages Rick Williams Tom WolffWorkshops Elyse Turner, Chair Ruben Diaz

3

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

gratefully acknowledges the generous support provided by our sponsors. The meeting would not exist without their support!

GOLD SPONSORS

BizInt SolutionsLinguamatics

STN

SILVER SPONSORS

EBSCOGenomeQuest

INTELLIXIRMinesoft

Search Technology/VantagePoint Technology & Patent Research International

BRONZE SPONSORS

ProQuest Dialog

4

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

Tuesday Morning 8:15 – 10:00 am | Chair: Alison Taylor

8:15 – 8:45 am Hindsight analysis of litigation-based investigations on best-practice searching for non-litigation matters

David A. Casimir (Casimir Jones, S.C.)

Abstract

Searching is often conducted in the context of patentability and freedom-to-operate investigations during early phases of technology and product development with the goal of best predicting what might happen to an intellectual property asset or technology through its lifespan. Budget constraints almost always necessarily limit the scope of such investigations. In contrast, when such economics become trivial, as in the case of patent litigation (regarding patentability) and substantial commercial success (regarding freedom-to-operate) – whether via blockbuster product, company acquisition, IPO, or other major transaction – budgets are often effectively unlimited when directed to the investigations of patentability and freedom-to-operate and may include the use of private detectives, expert interviews, and international travel. Using several case studies, this presentation will highlight the most valuable items identified when budgets were no issue to help identify and suggest best practices for maximizing the chances of finding such items (to the extent possible) when budgets are more limited. The benefit of conducting at least limited detective work into the historical context of a technology will be emphasized.

Biography

Dr. Casimir is a founding shareholder of Casimir Jones, SC located in Madison, Wisconsin and is also an adjunct Professor at the University of Wisconsin Law School. He was educated at the University of Michigan – Ann Arbor where he obtained a BS in Cellular and Molecular Biology. He then gained a PhD in Biochemistry from the University of Wisconsin – Madison and a law degree from Stanford Law School.

Dr. Casimir counsels clients in all areas of intellectual property including patents, trademarks, copyrights, and trade secrets. He has participated in the prosecution of over a thousand patent applications spanning topics such as molecular diagnostics, imaging systems, disease therapies, drugs, vaccines, drug delivery systems, research tools, enzymes, genes, artificial organs, transgenic animals, stem cells, nucleic acid synthesis, organic synthesis, multimedia information processing, material sciences, sensory substitution and enhancement, medical devices, nutraceuticals, ballistics systems, software, and Internet applications.

Dr. Casimir has worked with numerous small and large companies, universities, and institutes on all aspects of the intellectual property life cycle. Dr. Casimir is also frequently engaged to provide freedom-to-operate opinions, including non-infringement and invalidity opinions.

5

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

Hindsight analysis of litigation-based investigations on best-practice searching for non-litigation mattersDavid A. Casimir (Casimir Jones, S.C.)

6

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

8:45 – 9:15 am Therapeutic Antibodies: Do’s and Don’ts for Freedom-to-Operate and Patentability Searching

Briana Erickson (Nelson Mullins Riley & Scarborough LLP)

Abstract

Therapeutic antibodies comprise an increasing proportion of drugs and drug candidates. Thirty-three therapeutic antibodies have received FDA approval in the US, and that number continues to rise. It is essential to conduct a comprehensive intellectual property clearance search prior to commercialization of an antibody product.

Potentially relevant IP may include patents drawn to antibodies that bind the target antigen, possess particular functional characteristics, have a particular epitope specificity, possess the same binding properties as a reference antibody, or contain defined CDR and/or variable region sequences.

What is the best way to identify these patents when conducting a freedom-to-operate assessment? We will walk through a step-by-step strategy for identifying patent documents relevant to a commercial antibody product. Specific considerations include identifying appropriate keywords for searching the patent literature in the antibody space, designing sequence-based searches for the antibody CDR and variable regions, searching the target antigen, and determining other technological areas where IP clearance may be needed. Exemplary patent claims that are easy to miss will be highlighted.

Biography

Briana Erickson is a member of the life sciences intellectual property group at Nelson Mullins Riley & Scarborough LLP in the Firm’s Boston office. Her practice focuses on patent portfolio management and intellectual property due diligence in the areas of biotechnology, pharmaceuticals, oncology, immunology, nutraceuticals, and molecular diagnostics. She has a PhD in Molecular Biology from Brown University, a BS in Biology from Boston College, and a JD from Suffolk University Law School.

Tuesday Morning 8:15 – 10:00 am | Chair: Alison Taylor

7

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

Therapeutic Antibodies: Do’s and Don’ts for Freedom-to-Operate and Patentability Searching Briana Erickson (Nelson Mullins Riley & Scarborough LLP)

8

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

9:15 – 9:45 am Striding Along the Cutting Edge of Biopatent SearchingBarbara Miller (Novartis Institutes for Biomedical Research)

Abstract

As biopatent searchers, we all want to maintain our competitive edge while being open to new techniques and technologies as they become available. How can we best do this in an efficient and effective way? This talk will provide both a managerial and a searcher perspective on the tools, techniques, and strategies that you need as a professional biopatent searcher. We’ll look at how you might go about breaking down a complex request into manageable parts, finding the relevant information, and presenting this information in such a way as to enable customers to make quick decisions. We’ll discuss how you might leverage existing assets while identifying and developing new skills to help you progress within your career. From advances in scientific technologies to utilizing current resources, we’ll discuss not only what you need to know to be successful, but also the most professional way to stay on the cutting edge.

Biography

Barbara Miller is currently the US Regional Head of the Search and Analytics Team at the Novartis Institutes for Biomedical Research (NIBR) in Cambridge, MA. Prior to joining Novartis in August of 2009, she was an Information Scientist at Pfizer in Groton, CT, where she supported a variety of research and development teams by providing literature, patent, regulatory, and competitive information. Barbara began her searching career at the Pfizer facility in Ann Arbor, MI, in 2001 as a biopatent searcher after completing a postdoctoral fellowship at the University of Michigan. She has a PhD in Biological Sciences from Emory University in Atlanta, GA, an MS in Regulatory Affairs and Quality Assurance from Temple University, and a BS in Chemistry from Rhodes College in Memphis, TN.

Tuesday Morning 8:15 – 10:00 am | Chair: Alison Taylor

9

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

Striding Along the Cutting Edge of Biopatent SearchingBarbara Miller (Novartis Institutes for Biomedical Research)

10

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

10:30 – 11:00 am The Impact of WIPO Standards on Sequence Searching Tara Rix & Tasha Witham (Harbor Consulting IP)

Abstract

Sequence Listing rules dictated by WIPO Standard ST.25 directly impact the content of sequence databases. As such, they directly influence search strategy and the manner in which search professionals formulate their approach. Searchers may have experience searching in the sequence databases, but how cognizant are searchers of the rules regarding the inclusion or exclusion of sequences in Sequence Listings? This presentation will cover this subject matter and discuss the impact of WIPO Standard ST.25 on searching, as well as venture into the proposed new WIPO Standard ST.26 and the hypothetical impact it may have on sequence searching.

Biographies

Tara Rix has been a searcher with Harbor Consulting IP Services, Inc. for almost 7 years. Her background is in Chemistry.

Tasha Witham has been a searcher with Harbor Consulting IP Services, Inc. for just over 6 years. Her background is in Biology.

Tuesday Morning 10:30 – 11:45 am | Chair: Greg Roland

11

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

The Impact of WIPO Standards on Sequence Searching Tara Rix & Tasha Witham (Harbor Consulting IP)

12

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

11:00 – 11:30 am Erroneous Patent Sequence ID Numbers in Major Sequence Databases

Ellen Sherin (Dupont) & Denis Bayada (GenomeQuest)

Abstract

Approximately 50% of patent records originating in DDBJ have misassigned Sequence Identifier Numbers in comparison to both the corresponding sequence listings and filed patent documents. The error originated in the treatment of JPO/WIPO documents by DDBJ, which changed the sequence order from the sequence listing, and made a consecutively-numbered nucleotide sequence block followed by an amino acid sequence block. This error first appears in DDBJ and is subsequently propagated to EMBL and Genbank, and any other databases that take their data feed directly from any of these databases. This error affects database records with JP and WO patent or publication numbers. These misassignments can be corrected by direct access to the JPO/WIPO sequence listings and, importantly, by a recent update of DDBJ’s published format.

Biography

Ellen Doran Sherin is a graduate of University of Massachusetts at Amherst and New Mexico State University, Las Cruces. She has worked at DuPont for over 30 years; in the biotech field for the majority of this time. She worked in the area of automated oligonucleotide synthesis during its infancy and was on the team that was first to sequence the AIDS virus in the mid 1980’s. She’s also worked in automated DNA sequencing and scientific IT, including management of commercial sequence databases. She’s worked in the patent area for the last seven years with a specialty in sequence search and analysis, and is both a searcher and licensed US patent agent. She’s also developed and implemented internal sequence search documentation and training programs.

Tuesday Morning 10:30 – 11:45 am | Chair: Greg Roland

13

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

Erroneous Patent Sequence ID Numbers in Major Sequence DatabasesEllen Sherin (Dupont) & Denis Bayada (GenomeQuest)

14

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

1:15 – 1:45 pm Development of CAMBIA, the Lens, and PatSeq Explorer – public global patent search resources

Richard Jefferson (Queensland University of Technology, Australia)

Abstract

The talk will focus on the Lens, a public global patent search site, and its associated PatSeq Toolkits. This includes mapping global patent-derived sequences onto genomes (human and others) with detailed analytical tools to search, explore claims, and so on. The Lens is a free and open service and aims to remain free, as opposed to “freemium”.

The Gates Foundation has just further committed serious funds from Global Health to build out Lens. A new Lens platform with a new User Experience and greatly enhanced collections management, annotation, sharing, etc is being launched on December 7th, 2013 and the talk will highlight the new features and functionality.

Biography

Richard is a molecular biologist, agricultural scientist, innovation systems strategist, and the leading exponent of ‘Innovation Cartography’. He is the Founder & CEO of Cambia, Professor at the Queensland University of Technology and Group Leader at National ICT Australia. Richard conducted the world’s first field release of a biotech crop and created, distributed and supported the most widely cited and licensed enabling plant biotechnology. In 1989, Richard founded Cambia as an autonomous global non-profit social enterprise.

He created the BiOS Initiative, the first patent-based open licensing commons, and Patent Lens, the leading public global patent search site. This work has led to the ‘The Lens’- a new digital public good to disrupt and democratize the innovation system.

Profiled in diverse media including The Economist, Newsweek, Nature and the New York Times, he has been named to the Scientific American List of the World’s 50 most influential technologists.

Tuesday Afternoon 1:15 – 2:30 pm | Chair: Kim Spytek

15

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

Development of CAMBIA, the Lens, and PatSeq Explorer – public global patent search resourcesRichard Jefferson (Queensland University of Technology, Australia)

16

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

1:45 – 2:15 pm Patent Databases Available from SIPO with a Focus on Searching China Medicine Patents

Binqiang Liu (University of New Hampshire School of Law)

Abstract

As of 2011, there had been almost 8.7 million patent applications submitted before SIPO, with more than 8.6 million patent documents published. With the skyrocketing trend of patent applications and granted patents especially in recent years, China has become one of the largest patent markets over the world.

In order to facilitate the public use and dissemination of China patent information, SIPO, the sole authoritative agency governing patent application and examination and other patent related polices, has made extensive efforts and provided several publicly accessible patent databases online.

This topic covers some of those main databases by shedding lights on the various features of the platforms including PSS, CNIPR and CTCMPD.

Focus will be on the CTCMPD, a human indexed and value-added patent search platform for searching China Medicine Patents. CTCMPD offers various search entrances and useful terminology dictionaries in Chinese traditional medicines and western medicines as well. This platform is almost the only existing free source to search for China Medicine Patents. Practical applications and cases will be discussed.

It is hoped that with information from this topic, practitioners in the bio- and medicine field can search for China Medicine Patents more efficiently and more cost-effectively.

Biography

Mr. Binqiang Liu is now an IP Law Master Student at UNH Law, New Hampshire. Before coming to the US, Mr. Liu was a patent examiner at SIPO (State Intellectual Property Office of China) for more than 7 years after his graduation in 2006. He has both Bachelor and Master Degrees in Engineering and an advanced-study Master degree in Civil and Commercial Law. His research interests extend from patent examination to patent policy and patent commercialization. He is experienced in patent analysis, patent market and NPE phenomenon. Mr. Liu speaks at IP forums and conferences held by various institutions, including Tsinghua University School of Law, Peking University School of Law and China Patent Agent Committee. He is member of AIPPI (Association Internationale pour la Protection de la Propriete Industrielle) and PIAC (Patent Information Annual Conference) China. Mr. Liu is a regular writer, and has published more than 20 papers on patent related topics published in journals within and outside SIPO.

Tuesday Afternoon 1:15 – 2:30 pm | Chair: Kim Spytek

17

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

Patent Databases Available from SIPO with a Focus on Searching China Medicine PatentsBinqiang Liu (University of New Hampshire School of Law)

18

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

3:00 – 3:30 pm A “Cheat Sheet” for Exclusivities – Learning Across Functional Groups

Bo Peng

Abstract

“What are the chances this product will get seven or more years of market exclusivity (through patents or otherwise)?” As searchers, we frequently receive this kind of request for information on pharmaceutical exclusivities. Whilst it may appear to be a simple question, the answer can be multifaceted. This discussion will summarize the types of exclusivities that a potential pharmaceutical product may be able to obtain once it enters the market, either through the regulatory agencies (e.g., the FDA) or through patents or a combination of the two. In addition, a “cheat sheet” will be presented to capture various possible scenarios and the factors that determine the exclusivity periods. The “cheat sheet” was developed at Ironwood Pharmaceuticals through a collaborative effort involving the Intellectual Property, Regulatory Affairs and Pharmaceutical Development groups. The presentation will also provide an overview of some of the resources that were used and the type of information that can be obtained from each of them. Finally, this presentation will discuss how this information can provide insight into the potential market value of the product and how it will aid internal researchers and business development teams to make the most comprehensive and informed decision.

Biography

Bo Peng is a patent analyst who has 10+ years of experience in biopharmaceutical R&D, intellectual property, competitive intelligence and project management. She has conducted numerous prior art searches and analyses to support patentability, FTO, infringement and validity analysis for both internal programs and in-licensing opportunities. She is also a registered Patent Agent with United States Patent and Trademark office. Bo has been an active volunteer with PIUG since 2012. Prior to becoming a searcher, Bo worked as a medicinal and combinatorial chemist. Bo has a M.S. in Organic Chemistry from North Carolina State University and a B.S. in Chemistry from Peking University.

Tuesday Afternoon 3:00 – 5:00 pm | Chair: Helen Oen

19

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

A “Cheat Sheet” for Exclusivities – Learning Across Functional Groups Bo Peng

20

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

3:30 – 5:00 pm Discussion Panel: How I Became a Biotechnology Patent Searcher

Gin Eggerichs, Ken Hoppe, Seth Mendelson, Ellen Sherin, and Alison Taylor

Each panelist will give a 10 minute talk on how they became a biotech patent searcher, and then all will participate in a question and answer session. We encourage members of the audience to share comments about how they learned to become a biotech searcher including any mentoring, training, and on the job experience that contributed to their skill set.

Panelist Biographies

Gin Eggerichs, AbbVie – Gin Eggerichs has a B.S. in Molecular Genetics and a Ph.D. in Molecular, Cellular, and Developmental Biology from The Ohio State University. After graduation, Gin worked as an Applications Specialist for Chemical Abstracts Service (CAS) for almost 6 years. As an Applications Specialist, she trained searchers at several pharmaceutical and chemical companies on search techniques such as text, patent search, and sequence searching using STN. In addition to her responsibilities to commercial customers, she also worked with the USPTO Patent Academy and Chinese Patent Academy (SIPO) and trained the newly enrolled examiners on STN search-ing. Gin joined the Abbott Legal Search team in 2012 and in 2013 moved to AbbVie Legal Search team after the company split. Gin’s primary focus is to conduct patent/legal/literature searches in the biological area supporting AbbVie business.Kenneth Hoppe, Science IP® – Ken is a Senior Searcher at Science IP®, The CAS Search Service; Chemical Ab-stracts Service is a division of the American Chemical Society. Prior to joining CAS in 2007, Ken worked for 12 years in the pharmaceutical industry at Pfizer, where he conducted molecular biology research in drug discovery for six years and then provided patent and scientific information research for in-house patent attorneys for six years. Prior to his pharmaceutical industry experience, Ken worked in numerous academic molecular biology research lab-oratories at Harvard Medical School, Beth Israel Hospital Boston, and the University of Connecticut Health Center’s Department of Biochemistry.Ken focuses on comprehensive biological and biosequence patent retrieval and analysis in support of patentability, freedom to operate, validity, infringement, and due diligence activities within the legal and corporate environment. Ken has a MS in biology.Seth Mendelson, Novartis Institutes for Biomedical Research (NIBR) – Seth Mendelson is a Patent and Scientific Ana-lyst in the NIBR Patents group at Novartis Institutes for Biomedical Research. He has a BS in animal science and an MS in physiology, both from the University of Rhode Island. He has held several positions, beginning at the bench in a microarray lab at the Genetics Institute, spending two years in the bioinformatics group at Wyeth and finally moving into patent searching. Seth began working as a patent analyst in 2004 and has been at Novartis since 2008.Ellen Doran Sherin, DuPont – See paper above.Alison Taylor, Abbott – Alison has a BSc in Biochemistry from the University of Surrey, U.K. and a PhD in Biochem-istry / Molecular Biology from King’s College London, U.K. Since moving to the States following completion of her PhD, Alison has worked as a researcher at Abbott, Chicago, in the Molecular Biology Dept. In 1995, she moved into the biomedical searching arena at Monsanto for the Nutrasweet and G.D. Searle divisions of the company. She was taught how to search the scientific literature by library staff and vendors during the course of her new career. Alison later became Manager of the Chemical and Biological Searchers team at Monsanto, Skokie, IL (later Pharma-cia Corp., later Pfizer, Inc.), and mainly worked with research scientists. After the Skokie site was closed down, she moved to a private search firm, Threshold Information, Inc., where her clients were from a more wide-ranging group of industries. Alison moved back to Abbott in 2009 and currently works in the Legal Dept. where she provides FTO, prior art and other IP information services in the biotech and life sciences areas for the attorneys.

Tuesday Afternoon 3:00 – 5:00 pm | Chair: Helen Oen

21

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

Discussion Panel: How I Became a Biotechnology Patent Searcher Gin Eggerichs, Ken Hoppe, Seth Mendelson, Ellen Sherin, and Alison Taylor

22

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

BizInt Solutions, Inc.BizInt Solutions, Inc. is a small software company based in southern California. We develop, market and support BizInt Smart Charts software products which help information specialists create, customize and distribute tabular reports and visualizations combining data from the leading patent, gene sequence, drug pipeline and clinical trial databases. Our customers include pharmaceutical, biotech, chemical, petroleum, and device manufacturing companies in North America, Europe, China, India and Japan.

LinguamaticsLinguamatics is a provider of market-leading text mining and text analytics software, which uses Natural Language Processing (NLP) for high-value knowledge discovery and decision support. Customers include 9 of the top 10 global pharmaceutical companies as well as the U.S. Food and Drug Administration (FDA). I2E can be used to mine a wide variety of text resources, such as patents, scientific literature, clinical trials data, news feeds and proprietary content. Linguamatics’ Patent Mining Solution enables break-through insights from tens of millions of full text patent applications and grant documents, in real time.

STNSTN® International, the premium online service in science and patent information, provides access to nearly 200 databases from renowned producers. Only STN offers CAplus, CAS REGISTRY, DWPI, and the various INPADOC databases on a single platform. Its powerful, transparent retrieval system helps find journal literature, patents, structures, sequences, properties, and other data. Also available are excellent analysis, visualization and post-processing tools. With precise and comprehensive information, STN supports information professionals in answering business-critical questions. STN is operated jointly by CAS and FIZ Karlsruhe worldwide and is represented in Japan by JAICI.

THANK YOU TO OUR GOLD SPONSORS!

23

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

IT’S HARD TO GET PROFESSIONAL RESULTS WITH AMATEUR TOOLS.

PROFESSIONALS SEARCH STN.

Your tool shouldn’t restrict your results. STN is the most complete search and retrieval platform for the world’s disclosed scientific and technical research. Only STN offers CAS’ REGISTRY and other authoritative databases, Thomson Reuters’ Derwent World Patents Index®, and the most complete offering of science and technical content along with unparalleled search precision. The world’s patent offices rely on STN, shouldn’t you? Learn more at cas.org or stn-international.com.

STN is operated jointly by CAS and FIZ Karlsruhe worldwide and is represented in Japan by JAICI.

24

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

Linguamatics Patent SolutionMaking the impossible possible

Save time - reduce the number of documents which need to be read

Automatically extract numerical information, chemicals, genes, diseases and more

Identify structurally similar chemicals, claim chains & information from tables

Ask one of our experts for a demo at the Linguamatics booth

www.linguamatics.compatents@linguamatics.com

25

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

The most comprehensive index of science, technical, medical and business content available all in one place.

This product provides a highly-relevant index of non-patent literature with links to millions of full-text articles and extensive back� les dating as far back as 1885.

Non-Patent Prior Art Source is ideal for:• intellectual

property managers• patent attorneys• patent examiners

For additional information about this new resource,contact your EBSCO Sales Representative Phone: 1-800-653-2726 Email: information@ebsco.com

Did you know?We’ve added massively to our team and have been manually curating tens of thousands of non-ST.25 documents since early 2013.

If you’ve ever doubted, GQ-Pat is now for sure the most comprehensive data-base for biological sequence IP on the planet.

If you’re searching any other data-base, you’re missing patented inven-tions in GQ-Pat.

Come to our booth for proof.

GenomeQuest is the world’s leading solution for biological sequence search in patented documents.

SILVER SPONSORS

26

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

Silver Sponsors

Advertisers

ANALYSE

VISUALIZATION

DETECTION

Gal

ets

Ble

us A

gen

ce +

33 (

0)4

92 7

2 27

19

INTELLIXIR system is a hosted and secure web application (SaaS: Software as a Service) which analyzes patents, scientifi c articles as well as clinical trials exported from enterprise, public and commercial sources.

The analyses generated by INTELLIXIR are customizable and graphically represented in dynamic and interactive web pages.

Our system is mainly used by large science and technology organizations in all Industries, including cosmetic, pharmaceutical, medical, material, chemical, and energy.

Now with

INTELLIXIR JV Data Cluster Generate an interactive cluster map of your documents, explore concepts and players behind each cluster, and refi ne your categorization with new custom fi elds. Data Cluster is the graphical clustering module developed for INTELLIXIR V9 to completethe categorization tools.

INTELLIXIR is a PIUG 2014 Biotech Conference Silver Sponsor

Our agenda of events is available on

www.intellixir.com

INTELLIXIRRELEASE

9.0

Business IntelligenceCompetition Monitoring

and Technological Watching Patent

& non-patent Literature

Download our booklet (PDF format).

NEW

NEW

You are welcome to join us on the occasion of the PIUG 2014 Biotechnology Conference at our booth for presentation and live demonstrations of our new version.

NEW

IntellixirReport Maker

DocumentRanking

IntellixirStatistic Maker

One Click Loading

27

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

Announcing Version 8VantagePoint Version 8 adds many new features and tools to the VantagePoint suite.

Parent and Child Fields with Table Views

Custom Templates for Super Profi le

Bubble Charts

And more…

For a free trial, visit our website or call us at

1.770.441.1457www.TheVantagePoint.com

Serious Software for Patent Analysis

Trust TPR, the premier patent and literature search �rm, to support you and provide the most reliable, e�cient and incisive patent searching to keep you on top of your game.

• Careful, intelligent searches

• Wide range of resources

• On-time delivery of results

Freedom-to-Operate

Custom Searching

Patentability

Validity

Request an

Estimate To

day!

The Most Trusted Name in Searching.SM

Your Trusted Biotech Search Partner

For information on how our team can help your team, contact us at:

+1 858.592.9084 or visit www.TPRinternational.com

28

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

ATTENDEES BY NAME

Atkinson, Kristine A-A Patent InvestigationsBayada, Denis GenomeQuestBaycroft, Jessica Bell, Jordan Global Patent SolutionsBenhamou, David Bernier, Rob Brown, Jim FIZ KarlsruheBurr, Rebekah Chemical Abstracts ServiceButler, Barbara SanofiChitty, Mary Cambridge HealthtechCoburn, James Harbor Consulting IPCummins, Gary FIZ-KarlsruheDanko, Anthony ProQuestDixon, Jim LinguamaticsDoak, Donald EBSCODoudement, Julien GenomeQuestEberle, Matthew BizInt SolutionsEggerichs, Gin-Yun AbbVieErickson, Briana Nelson Mullins Riley & Scarborough Fiala, Jeannette Global Prior ArtFisher, Donna Biomeasure, Inc.Gore Willse, Ann Boehringer IngelheimGuo, Yujie Oklahoma State UnivHeinrich, Julia Bristol-Myers SquibbHoppe, Kenneth Science IPHumel Denton, Alice Chemical Abstracts ServiceJefferson, Richard CambiaKowalski, Stanley Univ of New Hampshire Kratunis, John Chemical Abstracts ServiceLiu, Binqiang UNH School of LawLowery, Drew Global Prior ArtMante, Eden Bristol-Myers SquibbMcConnell, Christopher AbbVie Mendelson, Seth Novartis Meng, Qin AmgenMiller, Barbara Novartis Milward, David LinguamaticsMintzes, Jeffrey PulmatrixMitchell, Steve TPRINauss, Jeff LinguamaticsOen, Helen Eisai Inc.O’Ryan, Rachel Ostanock, Phillip MinesoftPeng, Bo Perkins, Bill Porier, Jean-Baptiste INTELLIXIR LLCPorter, Alan Search Technology

Raju, Elangovan E-Merge techRaymond, Brent MinesoftRix, Tara Robins, Suzanne Patent Information ServRoland, Greg MerckSaha, Tapas Scism, Jennifer DeMarco IPShanker, Sumana Shire PharmaceuticalsSherin, Ellen DuPontSteel, Richard GenzymeTaylor, Alison AbbottThompson, Jane Eisai Inc.Tragert, Joseph Turner, Elyse Tzimas, Maritsa GlaxoSmithKlinevan der Zee, Doug MinesoftWeiss-Nolen, Monica sanofi pasteurWilliams, Richard Zoetis Willmore, John BizInt SolutionsWitham, Tasha Harbor Consulting IPWrzesinski, Eric Global Patent SolutionsZajac, Irene Global Patent Solutions

29

PIUG

2014 Biotechnology C

onference n C

ambridge, M

A

ATTENDEES BY COMPANY

A-A Patent Investigations Kristine AtkinsonAbbott Alison TaylorAbbVie Gin-Yun EggerichsAbbVie Christopher McConnellAmgen Qin MengBiomeasure, Inc. Donna FisherBizInt Solutions Matthew EberleBizInt Solutions John WillmoreBoehringer Ingelheim Ann Gore WillseBristol-Myers Squibb Julia HeinrichBristol-Myers Squibb Eden ManteCambia Richard JeffersonCambridge Healthtech Mary ChittyChemical Abstracts Service Rebekah BurrChemical Abstracts Service Alice Humel DentonChemical Abstracts Service John KratunisDeMarco IP Jennifer ScismDuPont Ellen SherinEBSCO Donald DoakEisai Inc. Helen OenEisai Inc. Jane ThompsonE-Merge tech Elangovan RajuFIZ Karlsruhe Jim BrownFIZ-Karlsruhe Gary CumminsGenomeQuest Denis BayadaGenomeQuest Julien DoudementGenzyme Richard SteelGlaxoSmithKline Maritsa TzimasGlobal Patent Solutions Jordan BellGlobal Patent Solutions Eric WrzesinskiGlobal Patent Solutions Irene ZajacGlobal Prior Art Jeannette FialaGlobal Prior Art Drew LoweryHarbor Consulting IP James CoburnHarbor Consulting IP Tasha WithamINTELLIXIR LLC Jean-Baptiste PorierLinguamatics Jim DixonLinguamatics David MilwardLinguamatics Jeff NaussMerck Greg RolandMinesoft Phillip OstanockMinesoft Brent RaymondMinesoft Doug van der ZeeNelson Mullins Riley & Scarborough Briana EricksonNovartis Seth MendelsonNovartis Barbara MillerOklahoma State Univ Yujie Guo

Patent Information Serv Suzanne RobinsProQuest Anthony DankoPulmatrix Jeffrey MintzesSanofi Barbara Butlersanofi pasteur Monica Weiss-NolenScience IP Kenneth HoppeSearch Technology Alan PorterShire Pharmaceuticals Sumana ShankerTPRI Steve MitchellUNH School of Law Binqiang LiuUniv of New Hampshire Stanley KowalskiZoetis Richard Williams Jessica Baycroft David Benhamou Rob Bernier Rachel O’Ryan Bo Peng Bill Perkins Tara Rix Tapas Saha Joseph Tragert Elyse Turner

30

PIU

G 2

014

Bio

tech

nolo

gy C

onfe

renc

e n

Cam

brid

ge, M

A

WORKSHOPS

Monday, February 24 – Boston Marriott Cambridge, 50 Broadway, Cambridge

9:30 am 10:00 am Breakfast (sponsored by BizInt Solutions)

10:00 am 12:00 noon BizInt Smart Charts: Developing a “Cookbook” of Reports and Visualizations to Support Drug Target and IP Analysis Instructors: John Willmore and Matt Eberle

12:00 noon 1:00 pm Lunch (sponsored by Linguamatics)

1:00 pm 3:00 pm Linguamatics I2E: Advancing Biotechnology Patent Search with Agile Text Mining Instructor: David Milward, CTO

3:00 pm 3:30 pm Break (sponsored by GenomeQuest)

3:30 pm 4:30 pm GenomeQuest: Tricks, Use Cases and Future Capabilities Instructor: Denis Bayada, Product Manager

Wednesday, February 26 – Genzyme, 675 W. Kendall Street, Washington Room, Cambridge

Please note: Attendees must sign-in with Security at the main Genzyme Center 500 Kendall Street, then be escorted across the street to the workshop room..8:30 am 11:00 am Information and Informatics in Living Systems: an Introduction to Molecular and

Genomic Biology Instructor: Paul Bain, Harvard University

11:30 am 1:30 pm Search for Sequences on STN – Going Beyond a Sequence Search Instructors: Jim Brown, FIZ-Karlsruhe & Alice Humel Denton, CAS

Lunch provided by STN

1:30 pm 4:30 pm Use of Cooperative Patent Classification (CPC) Instructors: Dr. Nathalie Loubradou-Bourges, Biotechnology Patent Examiner, EPO and Jerry Lorengo, Director Technology Center 1600, USPTO

Thursday - Friday, February 27-28 – Genzyme, 675 W. Kendall Street, Washington Room, Cambridge

Please note: Attendees must sign-in with Security at the main Genzyme Center 500 Kendall Street, then be escorted across the street to the workshop room.7:30 am 8:00 am Breakfast

8:00 am 4:30 pm (Thursday)

4:00 pm (Friday)

PIUG “Patent Information Fundamentals” Course (Fee and Registration Required)

Instructors: •Edlyn Simmons, Simmons Patent Information Service, LLC•Rachel Pilloff, Esq., Foley & Lardner LLC•Anthony Arleth, Pennside Partners Limited•Dominic Demarco, DeMarco IP•Kimberly Miller, Novartis•Tony Trippe, Patinformatics, LLC

Saturday, April 26 – Thursday, May 1, 2014Hyatt Regency Orange County

11999 Harbor BlvdGarden Grove, CA 92840

Patent Knowledge & IP StrategyRiding the Waves of Change to Achieve Business Success

The title of his presentation will be The Past Present & Future of Computer Curation of Patents & Scientific Literature. Dr. Boyer is truly a learned scientist who has achieved many remarkable milestones in the patent information industry.  In the interdisciplinary area of chemistry and computer science Dr. Boyer pioneered the use of computers to automatically

curate scientific literature and patents, thereby expanding the utility of published information in biomedicine, the physical sciences and intellectual property. More recently, he initiated a collaboration of pharmaceutical industry leaders and international governmental organizations to enhance access and curation of scientific information. This formed not only the basis of a new commercial offering for IBM but also the donation of ~ 2 million molecular structures to NIH as a PubChem deposition. His background combines ten years of experience in the pharmaceutical industry (Ciba-Geigy / Novartis) with 25 years at IBM.

Keynote Speaker- Dr. Stephen Boyer, Research Solutions for the ChemPharma Industry, IBM Almaden Research Center

Conference FeaturesThose who have a professional, scientific, or technical interest in patents and represent a multitude of companies

Who should attend

The conference will feature world-renowned experts on patent information for technology research and planning, for legal organizations, and for overall corporate IP management including technology licensing and related activities. The conference will include many opportunities for discussion and part of Tuesday afternoon will be dedicated to visiting the exhibit hall. Many workshops will also be held in conjunction with this meeting (before, during and after the technical sessions).

Saturday – Sunday: pre-conference workshops Sunday: network with colleagues and fellow PIUG members at the Welcome ReceptionMonday – Wednesday: Technical plenary sessions and exhibit hall openMonday: Gala Awards DinnerThursday: post-conference workshops

Why join us inGarden Grove

Agenda

Patent Information Users Group, Inc.40 E.Main Street, #1438 • Newark, DE 19711

Phone: (302) 660-3275 • Email: PIUGinfo@piug.orgwww.piug.org

Early bird registration rates end March 7, 2014.Note: Take advantage of discounted member registration fees by renewing or becoming a PIUG member at: http://www.piug.org/membership.

Register NowTo register online, visit

http://piug.org/an14reg

Don’t get caught with dirty data

In any given landscape, there’s going to be some dirt.

You need tools to help you see where to dig deeper. Some types of information you want to scan at the family level and some you want to dig down to individual family members. You might want to see one priority date per family but legal status for each member. Sequences add another layer of complexity with multiple sequences per patent document.

The latest tools in the BizInt Smart Charts product family will help you create accurate and useful patent reports — with the right level of detail to help you decide where to start digging.

Get a Closer Look! Go to www.bizint.com/CookbookThe Cookbook of Reports and Visualizations shows how you can use BizInt Smart Charts software to create, customize and distribute

competitive intelligence reports and visualizations from drug pipeline, clinical trial, patent and gene sequence databases.

The BizInt Smart Charts product family is used by pharmaceutical, biotech and medical device/

diagnostics companies worldwide to support product lifecycle planning and management.

Visit us in the exhibit hall for samples and a demonstration!

BizInt Solutions, Inc.1.714.289.1000www.bizint.com

Software for Business Intelligence